Zevra’s Arimoclomol Brings Efficacy Questions To First Genetic Metabolic Diseases Adcomm

 
• By Sue Sutter
  
Wrapped package
The FDA's external advisors will consider a package of confirmatory trial evidence for arimoclomol. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers